Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($) $ in Thousands |
Total |
Series B1 Preferred Stock |
Previously Reported |
Preferred Stock |
Preferred Stock
Previously Reported
|
Common Stock |
Common Stock
Series B1 Preferred Stock
|
Common Stock
Series D Preferred Stock
|
Common Stock
Previously Reported
|
Additional Paid-In Capital |
Additional Paid-In Capital
Series B1 Preferred Stock
|
Additional Paid-In Capital
Previously Reported
|
Accumulated Deficit |
Accumulated Deficit
Previously Reported
|
Accumulated Other Comprehensive Loss |
Accumulated Other Comprehensive Loss
Previously Reported
|
Beginning Balance (in shares) at Dec. 31, 2020 |
|
|
|
|
0
|
[1] |
22,579,695
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock, Beginning Balance (in shares) at Dec. 31, 2020 |
|
|
|
|
|
|
|
32,184,263
|
[1] |
|
|
16,211,567
|
|
|
|
|
|
|
|
|
|
|
Beginning Balance at Dec. 31, 2020 |
$ (1,847)
|
[1] |
|
$ (1,847)
|
|
|
$ 2
|
$ 3
|
[1] |
|
|
$ 2
|
$ 112,994
|
[1] |
|
$ 112,993
|
$ (114,567)
|
[1] |
$ (114,567)
|
$ (277)
|
[1] |
$ (277)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of Legacy Shapeways common stock upon exercise of stock options (Shares) |
|
|
|
|
|
|
|
35,895
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of Legacy Shapeways common stock upon exercise of stock options |
16
|
|
|
|
|
|
|
|
|
|
|
|
16
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense |
174
|
|
|
|
|
|
|
|
|
|
|
|
174
|
|
|
|
|
|
|
|
|
|
Net (loss) income |
1,708
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,708
|
|
|
|
|
|
Foreign currency translation adjustment |
(9)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(9)
|
|
|
Ending Balance at Mar. 31, 2021 |
42
|
|
|
|
$ 0
|
|
|
$ 3
|
|
|
|
|
113,184
|
|
|
|
(112,859)
|
|
|
(286)
|
|
|
Ending Balance (in shares) at Mar. 31, 2021 |
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock, Ending Balance (in shares) at Mar. 31, 2021 |
|
|
|
|
|
|
|
32,220,158
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning Balance (in shares) at Dec. 31, 2020 |
|
|
|
|
0
|
[1] |
22,579,695
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock, Beginning Balance (in shares) at Dec. 31, 2020 |
|
|
|
|
|
|
|
32,184,263
|
[1] |
|
|
16,211,567
|
|
|
|
|
|
|
|
|
|
|
Beginning Balance at Dec. 31, 2020 |
(1,847)
|
[1] |
|
$ (1,847)
|
|
|
$ 2
|
$ 3
|
[1] |
|
|
$ 2
|
112,994
|
[1] |
|
$ 112,993
|
(114,567)
|
[1] |
$ (114,567)
|
(277)
|
[1] |
$ (277)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income |
4,125
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustment |
(39)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending Balance at Sep. 30, 2021 |
84,368
|
|
|
|
$ 0
|
|
|
$ 5
|
|
|
|
|
195,121
|
|
|
|
(110,442)
|
|
|
(316)
|
|
|
Ending Balance (in shares) at Sep. 30, 2021 |
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock, Ending Balance (in shares) at Sep. 30, 2021 |
|
|
|
|
|
|
|
48,296,484
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning Balance (in shares) at Mar. 31, 2021 |
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock, Beginning Balance (in shares) at Mar. 31, 2021 |
|
|
|
|
|
|
|
32,220,158
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning Balance at Mar. 31, 2021 |
42
|
|
|
|
$ 0
|
|
|
$ 3
|
|
|
|
|
113,184
|
|
|
|
(112,859)
|
|
|
(286)
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of Legacy Shapeways common stock upon exercise of stock options (Shares) |
|
|
|
|
|
|
|
63,506
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of Legacy Shapeways common stock upon exercise of stock options |
55
|
|
|
|
|
|
|
|
|
|
|
|
55
|
|
|
|
|
|
|
|
|
|
Issuance of Legacy Shapeways convertible Series preferred stock resulting from exercise of warrants (shares) |
|
|
|
|
|
|
|
|
|
19,177
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of Legacy Shapeways convertible Series preferred stock resulting from exercise of warrants (shares) |
|
|
$ 60
|
|
|
|
|
|
|
|
|
|
|
|
$ 60
|
|
|
|
|
|
|
|
Stock-based compensation expense |
171
|
|
|
|
|
|
|
|
|
|
|
|
171
|
|
|
|
|
|
|
|
|
|
Net (loss) income |
(135)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(135)
|
|
|
|
|
|
Foreign currency translation adjustment |
(8)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(8)
|
|
|
Ending Balance at Jun. 30, 2021 |
185
|
|
|
|
$ 0
|
|
|
$ 3
|
|
|
|
|
113,470
|
|
|
|
(112,994)
|
|
|
(294)
|
|
|
Ending Balance (in shares) at Jun. 30, 2021 |
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock, Ending Balance (in shares) at Jun. 30, 2021 |
|
|
|
|
|
|
|
32,302,841
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of Legacy Shapeways common stock upon exercise of stock options (Shares) |
|
|
|
|
|
|
|
1,113,029
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of Legacy Shapeways common stock upon exercise of stock options |
481
|
|
|
|
|
|
|
|
|
|
|
|
481
|
|
|
|
|
|
|
|
|
|
Issuance of Legacy Shapeways convertible Series preferred stock resulting from exercise of warrants (shares) |
|
|
|
|
|
|
|
|
|
|
89,217
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of Legacy Shapeways common stock upon conversion of convertible notes (shares) |
|
|
|
|
|
|
|
1,406,741
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of Legacy Shapeways common stock upon conversion of convertible notes |
5,913
|
|
|
|
|
|
|
|
|
|
|
|
5,913
|
|
|
|
|
|
|
|
|
|
Issuance of Legacy Shapeways common stock upon exercise of warrants (shares) |
|
|
|
|
|
|
|
212,234
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Repurchase of Legacy Shapeways common stock (shares) |
|
|
|
|
|
|
|
(19,226)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Repurchase of Legacy Shapeways common stock |
(152)
|
|
|
|
|
|
|
|
|
|
|
|
(152)
|
|
|
|
|
|
|
|
|
|
Effect of Merger and recapitalization, net of redemptions and issuance costs (shares) |
|
|
|
|
|
|
|
5,691,648
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of Merger and recapitalization, net of redemptions and issuance costs |
10,036
|
|
|
|
|
|
|
$ 1
|
|
|
|
|
10,035
|
|
|
|
|
|
|
|
|
|
Issuance of common stock pursuant to PIPE financing, net of issuance costs (shares) |
|
|
|
|
|
|
|
7,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock pursuant to PIPE financing, net of issuance costs |
64,937
|
|
|
|
|
|
|
$ 1
|
|
|
|
|
64,936
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense |
438
|
|
|
|
|
|
|
|
|
|
|
|
438
|
|
|
|
|
|
|
|
|
|
Net (loss) income |
2,552
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,552
|
|
|
|
|
|
Foreign currency translation adjustment |
(22)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(22)
|
|
|
Ending Balance at Sep. 30, 2021 |
$ 84,368
|
|
|
|
$ 0
|
|
|
$ 5
|
|
|
|
|
195,121
|
|
|
|
(110,442)
|
|
|
(316)
|
|
|
Ending Balance (in shares) at Sep. 30, 2021 |
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock, Ending Balance (in shares) at Sep. 30, 2021 |
|
|
|
|
|
|
|
48,296,484
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning Balance (in shares) at Dec. 31, 2021 |
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock, Beginning Balance (in shares) at Dec. 31, 2021 |
48,627,739
|
|
|
|
|
|
|
48,627,739
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning Balance at Dec. 31, 2021 |
$ 85,004
|
|
|
|
$ 0
|
|
|
$ 5
|
|
|
|
|
198,179
|
|
|
|
(112,811)
|
|
|
(369)
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of Legacy Shapeways common stock upon exercise of stock options (Shares) |
217,967
|
|
|
|
|
|
|
217,967
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of Legacy Shapeways common stock upon exercise of stock options |
$ 99
|
|
|
|
|
|
|
|
|
|
|
|
99
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense |
312
|
|
|
|
|
|
|
|
|
|
|
|
312
|
|
|
|
|
|
|
|
|
|
Net (loss) income |
(4,037)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(4,037)
|
|
|
|
|
|
Transfer of Private Warrants to Public Warrants |
382
|
|
|
|
|
|
|
|
|
|
|
|
382
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustment |
(52)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(52)
|
|
|
Ending Balance at Mar. 31, 2022 |
$ 81,708
|
|
|
|
$ 0
|
|
|
$ 5
|
|
|
|
|
198,972
|
|
|
|
(116,848)
|
|
|
(421)
|
|
|
Ending Balance (in shares) at Mar. 31, 2022 |
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock, Ending Balance (in shares) at Mar. 31, 2022 |
|
|
|
|
|
|
|
48,845,706
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning Balance (in shares) at Dec. 31, 2021 |
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock, Beginning Balance (in shares) at Dec. 31, 2021 |
48,627,739
|
|
|
|
|
|
|
48,627,739
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning Balance at Dec. 31, 2021 |
$ 85,004
|
|
|
|
$ 0
|
|
|
$ 5
|
|
|
|
|
198,179
|
|
|
|
(112,811)
|
|
|
(369)
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income |
(13,261)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustment |
(351)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending Balance at Sep. 30, 2022 |
$ 73,870
|
|
|
|
$ 0
|
|
|
$ 5
|
|
|
|
|
200,657
|
|
|
|
(126,072)
|
|
|
(720)
|
|
|
Ending Balance (in shares) at Sep. 30, 2022 |
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock, Ending Balance (in shares) at Sep. 30, 2022 |
49,294,285
|
|
|
|
|
|
|
49,294,285
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning Balance (in shares) at Mar. 31, 2022 |
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock, Beginning Balance (in shares) at Mar. 31, 2022 |
|
|
|
|
|
|
|
48,845,706
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning Balance at Mar. 31, 2022 |
$ 81,708
|
|
|
|
$ 0
|
|
|
$ 5
|
|
|
|
|
198,972
|
|
|
|
(116,848)
|
|
|
(421)
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of Legacy Shapeways common stock upon exercise of stock options (Shares) |
367,732
|
|
|
|
|
|
|
367,732
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of Legacy Shapeways common stock upon exercise of stock options |
$ 189
|
|
|
|
|
|
|
|
|
|
|
|
189
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense |
457
|
|
|
|
|
|
|
|
|
|
|
|
457
|
|
|
|
|
|
|
|
|
|
Net (loss) income |
(4,674)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(4,674)
|
|
|
|
|
|
Transfer of Private Warrants to Public Warrants |
288
|
|
|
|
|
|
|
|
|
|
|
|
288
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustment |
(174)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(174)
|
|
|
Ending Balance at Jun. 30, 2022 |
$ 77,794
|
|
|
|
$ 0
|
|
|
$ 5
|
|
|
|
|
199,906
|
|
|
|
(121,522)
|
|
|
(595)
|
|
|
Ending Balance (in shares) at Jun. 30, 2022 |
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock, Ending Balance (in shares) at Jun. 30, 2022 |
|
|
|
|
|
|
|
49,213,438
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of Legacy Shapeways common stock upon exercise of stock options (Shares) |
68,817
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock issued for stock-based compensation (in shares) |
|
|
|
|
|
|
|
80,847
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock issued for stock-based compensation |
$ 1
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense |
750
|
|
|
|
|
|
|
|
|
|
|
|
750
|
|
|
|
|
|
|
|
|
|
Net (loss) income |
(4,550)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(4,550)
|
|
|
|
|
|
Foreign currency translation adjustment |
(125)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(125)
|
|
|
Ending Balance at Sep. 30, 2022 |
$ 73,870
|
|
|
|
$ 0
|
|
|
$ 5
|
|
|
|
|
$ 200,657
|
|
|
|
$ (126,072)
|
|
|
$ (720)
|
|
|
Ending Balance (in shares) at Sep. 30, 2022 |
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock, Ending Balance (in shares) at Sep. 30, 2022 |
49,294,285
|
|
|
|
|
|
|
49,294,285
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|